S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
S&P 500   3,850.78
DOW   31,169.48
QQQ   323.63
Log in

Acasti Pharma Inc. (ACST.V) Stock Forecast, Price & News

+0.07 (+8.64 %)
(As of 01/20/2021 01:45 PM ET)
Today's Range
Now: C$0.88
50-Day Range
MA: C$0.48
52-Week Range
Now: C$0.88
Volume949,132 shs
Average Volume1.53 million shs
Market CapitalizationC$85.27 million
P/E RatioN/A
Dividend YieldN/A
Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of prescription drugs for the treatment of cardiovascular diseases. Its lead product candidate is CaPre, an omega-3 phospholipid therapeutic that is in Phase III clinical trial to treat patients with hypertriglyceridemia; and TRILOGY that is in Phase III to evaluate the safety and efficacy of CaPre in patients with sHTG. The company was incorporated in 2002 and is headquartered in Laval, Canada.


Overall MarketRank

0.54 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Biotechnology



Sales & Book Value

Annual SalesN/A
Cash FlowC$0.15 per share
Book ValueC$0.09 per share



Market CapC$85.27 million
Next Earnings DateN/A
OptionableNot Optionable
+0.07 (+8.64 %)
(As of 01/20/2021 01:45 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ACST News and Ratings via Email

Sign-up to receive the latest news and ratings for ACST and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Acasti Pharma Inc. (ACST.V) (CVE:ACST) Frequently Asked Questions

How has Acasti Pharma Inc. (ACST.V)'s stock price been impacted by Coronavirus (COVID-19)?

Acasti Pharma Inc. (ACST.V)'s stock was trading at C$0.54 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ACST shares have increased by 63.0% and is now trading at C$0.88.
View which stocks have been most impacted by COVID-19

What stocks does MarketBeat like better than Acasti Pharma Inc. (ACST.V)?

Wall Street analysts have given Acasti Pharma Inc. (ACST.V) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Acasti Pharma Inc. (ACST.V) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Acasti Pharma Inc. (ACST.V)'s key competitors?

What other stocks do shareholders of Acasti Pharma Inc. (ACST.V) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma Inc. (ACST.V) investors own include Matinas BioPharma (MTNB), Aurora Cannabis Inc. (ACB.TO) (ACB), SCYNEXIS (SCYX), Square (SQ), Nokia (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA).

Who are Acasti Pharma Inc. (ACST.V)'s key executives?

Acasti Pharma Inc. (ACST.V)'s management team includes the following people:
  • Ms. Janelle D' Alvise, Pres, CEO, Corp. Sec. & Director (Age 66, Pay $565.48k)
  • Dr. Pierre Lemieux, Co-Founder, COO & Chief Scientific Officer (Age 56, Pay $344.15k)
  • Mr. Brian D. Ford CPA, CA, Chief Financial Officer

What is Acasti Pharma Inc. (ACST.V)'s stock symbol?

Acasti Pharma Inc. (ACST.V) trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ACST."

How do I buy shares of Acasti Pharma Inc. (ACST.V)?

Shares of ACST and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

What is Acasti Pharma Inc. (ACST.V)'s stock price today?

One share of ACST stock can currently be purchased for approximately C$0.88.

How big of a company is Acasti Pharma Inc. (ACST.V)?

Acasti Pharma Inc. (ACST.V) has a market capitalization of C$85.27 million. Acasti Pharma Inc. (ACST.V) employs 32 workers across the globe.

What is Acasti Pharma Inc. (ACST.V)'s official website?

The official website for Acasti Pharma Inc. (ACST.V) is www.acastipharma.com.

How can I contact Acasti Pharma Inc. (ACST.V)?

Acasti Pharma Inc. (ACST.V)'s mailing address is 545 Prom du Centropolis Suite 100, LAVAL, QC H7T 0A3, Canada. The company can be reached via phone at +1-450-6864555.

This page was last updated on 1/20/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.